Taken together, these data suggest that the p19Arf-Mdm2-p53 pathway, rather than the RP-Mdm2-p53 pathway, is the main barrier to suppress APT121-induced prostate cancer. The gene discussed is MDM2; the disease is prostate carcinoma.